CapitalBiotech SARS-CoV-2 Integrated Microfluidic Chip Analysis System
The system, incorporating two cutting-edge technologies, provides a “sample in, result out”testing mode within 45 mins, including sample lysis, nucleic acid extraction, on-chip nested isothermal amplification, and fluorescence detection.
CapitalBiotech®BioelectronSeq 4000 Sequencer
The BES 4000 is a high-throughput gene sequencer for genetic testing. It’s joined by an automatic nucleic acid preparation machine, a gene amplification apparatus, and other tools.
CapitalBiotech Centrifugal Heat Sealing Machine
Integrate the functions of chip centrifugation and chip heat sealing within one instrument, and the two parts can be operated simultaneously without interfering with each other.
Respiratory Pathogens Nucleic Acid Detection
Using microfluidic technology, it’s widely used in pathogen screening of patients with respiratory infection symptoms, shortening treatment cycles and providing a scientific basis for clinical medication.
Preimplantation Embryo Genetic Screening (PGS)
PGS is an early prenatal screening method that detects and analyzes abnormalities in the number of chromosomes and structure of early embryos before implantation.
Precise Diagnosis and Treatment for Brain Cancer
This test comprehensively detects the molecular signatures of relevant tumor drugs approved by NMPA/FDA, as well as the genes related to typing, diagnosis, prognosis and medication in NCCN/CSCO/WHO guidelines, brain tumor research and related clinical trials.
HLA Typing
The HLA (human leucocyte antigen) system encodes the major histocompatibility complex (MHC) proteins in humans and is closely related to the body's immune system.
Fully Integrated Automatic On-site Quick DNA Test System Quick TargSeq B
The Fully Integrated Automatic On-site Quick DNA Test System Quick TargSeq B, a jointly developed forensic platform with independent intellectual property rights by the Institute of Forensic Science of China, Tsinghua University, CapitalBio Group, and CapitalBio Technology, adopts modular microfluidic chip technology to integrate the entire testing process from sample preprocessing to result output, enabling fully automated on-site DNA testing in 2 hours in extreme environments such as high altitudes (0-5000m) and vehicle-mounted conditions, supporting multiple sample types and reagent functions for various forensic and public security application scenarios.
CapitalBiotech COVID-19 Mobile Laboratory
Integrated with global leading chip laboratory technology and swab robot sampling technology, COVID-19 Mobile Laboratory enables "sample in, result out" detection that is borh suscepible and rapid in various demand scenarios, such as border ports, CDC, grassroots hospitals, etc.